Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / WINT - Windtree receives US patent for istaroxime to treat acute heart failure


WINT - Windtree receives US patent for istaroxime to treat acute heart failure

  • Windtree Therapeutics ( NASDAQ: WINT ) said on Tuesday the United States Patent and Trademark Office (USPTO) had issued a new patent for istaroxime administration, an investigational drug candidate in early cardiogenic shock and acute heart failure.
  • The company said Phase 2 studies in acute heart failure have showed significant improvements in cardiac function as well as increasing blood pressure and preserving or increasing renal function.
  • ( WINT ) has risen ~5% before the bell.

For further details see:

Windtree receives US patent for istaroxime to treat acute heart failure
Stock Information

Company Name: Windtree Therapeutics Inc.
Stock Symbol: WINT
Market: OTC
Website: windtreetx.com

Menu

WINT WINT Quote WINT Short WINT News WINT Articles WINT Message Board
Get WINT Alerts

News, Short Squeeze, Breakout and More Instantly...